ATXIAVENUE THERAPEUTICS, INC.


$ 2.65 $ -0.02 (-0.71 %)    

Monday, 16-Sep-2024 09:37:26 EDT
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ na
$ 2.65
$ 2.70 x 100
-- x --
$ 2.65 - $ 2.65
$ 2.25 - $ 64.27
20,398
na
3.99M
$ 0.26
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 avenue-therapeutics-q2-eps-643-misses-105-estimate

Avenue Therapeutics (NASDAQ:ATXI) reported quarterly losses of $(6.43) per share which missed the analyst consensus estimate of...

 avenue-therapeutics-q1-eps-1540-misses-900-estimate

Avenue Therapeutics (NASDAQ:ATXI) reported quarterly losses of $(15.40) per share which missed the analyst consensus estimate o...

 avenue-therapeutics-may-offer-shares-of-common-stock-having-offering-price-of-up-to-39m-from-time-to-time-through-agent

- SEC Filing

 why-avenue-therapeutics-atxi-stock-is-falling-sharply

Avenue Therapeutics shares are trading lower by 20.7% during Monday's session. The company announced the exercise of warran...

 why-avenue-therapeutics-atxi-shares-are-getting-hammered

Avenue Therapeutics shares are trading lower by 28.5% during Wednesday's session. The company is implementing a 1-for-75 re...

 avenue-therapeutics-plans-to-effect-1-for-75-reverse-split-of-its-issued-and-outstanding-common-stock

Avenue expects its common stock to begin trading on a split-adjusted basis on the Nasdaq Capital Market as of the commencement ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION